Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

Share :
Published: 27 Apr 2015
Views: 2526
Rating:
Save
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA

Dr Hodi presents the findings of a phase II trial of an ipilimumab-nivolumab combo, which showed promise in advanced melanoma, during a press conference at AACR 2015.

Read the news story for more.